Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
Clinical Biochemistry|August 24, 2006
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCRMaria Ntoulia, Aliki Stathopoulou, Michail Ignatiadis, et al.
Cancer Treatment Reviews|July 28, 2017
Fertility and pregnancy issues in BRCA-mutated breast cancer patientsMatteo Lambertini, Oranite Goldrat, Angela Toss, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2019
Early prediction of neoadjuvant treatment outcome in locally advanced breast cancer using parametric response mapping and radial heterogeneity from breast MRIStylianos Drisis, Mohammed El Adoui, Patrick Flamen, et al.
Anticancer Research|November 27, 2008
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trialIoannis Gioulbasanis, Zacharenia Saridaki, Antonia Kalykaki, et al.
Oncology|July 25, 2007
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancerMichail Ignatiadis, Aris Polyzos, George P Stathopoulos, et al.
Plos One|May 3, 2013
Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysisHatem A Azim, Sandeep Singhal, Michail Ignatiadis, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2023
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, et al.
Frontiers in Oncology|August 20, 2021
Circulating Tumor DNA to Interrogate the Safety of Letrozole-Associated Controlled Ovarian Stimulation for Fertility Preservation in Breast Cancer PatientsFrançoise Rothé, Matteo Lambertini, Oranite Goldrat, et al.
Clinical Breast Cancer|February 14, 2008
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancerMichail Ignatiadis, Maria Perraki, Stella Apostolaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancerMichail Ignatiadis, Galatea Kallergi, Maria Ntoulia, et al.
Pageof 10